Pandox AB (publ) (PNDX-B)
Stockholm Exchange · Sweden · prices in SEK · close of 19 Oct 2026
Key indicators
| Last close | SEK 158.80 |
|---|---|
| 52-week range | 147.00 – 200.34 |
| Return, 1 month / 3 months | −4.0% / −5.9% |
| Return, 1 year / 3 years | −12.2% / +46.9% |
| Trend | Below its 200-day average |
| RSI (14) | 51 |
| Volatility (1 year) | 22.6% |
| Worst drawdown (1 year) | -25.0% |
| Average daily value traded | 17.48M SEK |
| Dividend yield | 2.8% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Pandox is a Swedish hotel property company that owns hotels in several European cities and earns income by leasing them to hotel operators, who run the properties under their own brands. The company also operates a number of its hotels directly through agreements with international hotel chains. Its customers are hotel operators and guests, and its head office is in Stockholm, Sweden.
On this site Pandox AB (publ) appears as a stock on the Stockholm Exchange (Sweden), code PNDX-B, with prices in Swedish kronor (SEK). Our dividend records, which start in 2019, show payments in 6 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Pandox AB (publ) (PNDX-B) trades on the Stockholm Exchange in Sweden. It last closed at SEK 158.80 on 19 October 2026.
Its price-based Market X-Ray is 60 out of 100 (a fair price profile), ranking 324 of 911 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price fell 12.2% and over the last three months it fell 5.9%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on Stockholm Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 47 · Weak | Below its long-term averages and far from its highs. | |
| Above 200-day average | -10.1% | ||
| From 52-week high | -20.0% | ||
| Momentum | 43 · Weak | Lagging most stocks on this exchange. | |
| 3-month return | -5.9% | ||
| 6-month return | -17.5% | ||
| 12-month return, skipping the last month | -8.5% | ||
| Stability (higher is calmer) | 85 · Strong | Calmer than most: low volatility and shallow drawdowns. | |
| Volatility, 1 year (lower is calmer) | 22.6% | ||
| Worst drawdown, 1 year (smaller is calmer) | -25.0% | ||
| Liquidity | 84 · Strong | Trades actively. | |
| Average daily value traded | 17.48M SEK | ||
| Zero-volume days | 0.0% | ||
| Income | 40 · Weak | Dividend is small or irregular. | |
| Dividend yield | 2.8% | ||
| Years with dividends | 4 |
Strengths
- Stability (higher is calmer): Calmer than most: low volatility and shallow drawdowns.
- Liquidity: Trades actively.
Weak spots
- Trend: Below its long-term averages and far from its highs.
- Momentum: Lagging most stocks on this exchange.
- Income: Dividend is small or irregular.
Returns
| 1 week | +5.4% |
|---|---|
| 1 month | −4.0% |
| 3 months | −5.9% |
| 6 months | −17.5% |
| 1 year | −12.2% |
| 3 years | +46.9% |
| 5 years | – |
Signals
| 50-day / 200-day average | 165.05 / 176.55 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | No |
| Bullish RSI divergence | Yes |
| Average daily range (ATR) | 4.06 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 16 Apr 2026 | SEK 4.5000 |
| 10 Apr 2025 | SEK 4.2500 |
| 11 Apr 2024 | SEK 4.0000 |
| 13 Apr 2023 | SEK 2.5000 |
| 6 Apr 2020 | SEK 34.7207 |
| 11 Apr 2019 | SEK 4.7000 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on Stockholm Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.